Celularity Inc
This role leads and maintains a phase-appropriate Quality Management System while providing GMP and GTP quality oversight to ensure compliance with FDA, EMA, and other regulatory standards. The position involves developing and executing analytical and microbiological quality control strategies, overseeing laboratory activities, and managing environmental monitoring programs. Additionally, the incumbent will develop regulatory strategies, lead the preparation of regulatory filings, and serve as the primary liaison with regulatory authorities.
Celularity Inc. (NASDAQ: CELU) is an innovative regenerative and cellular medicine company that develops and commercializes advanced biomaterial products and allogeneic, cryopreserved cell therapies derived from the postpartum placenta. The company's pipeline focuses on placental-derived cell therapies including MLASCs, Natural Killer (NK) cells, and engineered T cells (including CAR-T cells), targeting age-related diseases. Celularity operates a fully integrated, purpose-built manufacturing and biobanking facility, aiming to deliver off-the-shelf cellular medicines at scale, quality, and accessible economics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celularity Inc.
Celularity Inc didn’t post a salary, so this is our estimate from similar listings.